EMRO D: Cost effectiveness results for Maternal and Neonatal Health
This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.
KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
-
Summary
Summary of the methodologies used in the analysis -
Published research report
pdf, 167kb -
Excel Spreadsheet
xls, 93kb
Download this table in excel
| Interventions:Codes_and_Descriptions | Coverage | Cost per year (I$, millions) per one million_population [i.e. cost per capita] | % Program costs | % Patient costs | DALYs averted per year per one million_population | Average Cost per DALY averted | Incremental Cost per DALY averted |
| MNH-1: Community newborn care package | 50% | 0.08 | 10% | 90% | 9,585 | 9 | Dominated |
| MNH-2: Support for breastfeeding mothers | 50% | 0.09 | 9% | 91% | 9,415 | 9 | Dominated |
| MNH-3: Pre-eclampsia screening | 50% | 0.04 | 12% | 88% | 161 | 228 | Dominated |
| MNH-4: Tetanus toxoid | 50% | 0.04 | 10% | 90% | 6,564 | 7 | Dominated |
| MNH-5: Screening & treatment of asymptomatic bacteriuria | 50% | 0.02 | 18% | 82% | 69 | 353 | Dominated |
| MNH-6: Screening & treatment of syphilis | 50% | 0.03 | 16% | 84% | 47 | 606 | Dominated |
| MNH-7: Normal delivery by a skilled attendant | 50% | 0.13 | 5% | 95% | 4,176 | 32 | Dominated |
| MNH-8: Community-based case management for neonatal pneumonia | 50% | 0.00 | 47% | 53% | 250 | 7 | Dominated |
| MNH-9: Normal delivery by a skilled attendant + Tetanus Toxoid | 50% | 0.18 | 4% | 96% | 7,245 | 24 | Dominated |
| MNH-10: Management of maternal sepsis | 50% | 0.10 | 3% | 97% | 65 | 1,534 | Dominated |
| MNH-11: Management of severe neonatal asphyxia | 50% | 0.02 | 25% | 75% | 12 | 2,034 | Dominated |
| MNH-12: Management of serious newborn infections | 50% | 0.10 | 6% | 94% | 312 | 332 | Dominated |
| MNH-13: Management of very low birth weight babies | 50% | 0.04 | 15% | 85% | 103 | 384 | Dominated |
| MNH-14: Manangement of neonatal jaundice | 50% | 0.02 | 26% | 74% | 4 | 5,452 | Dominated |
| MNH-15: Tetanus toxoid + Pre-eclampsia screening | 50% | 0.07 | 8% | 92% | 6,726 | 10 | Dominated |
| MNH-16: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 50% | 0.07 | 13% | 87% | 6,796 | 10 | Dominated |
| MNH-17: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 50% | 0.07 | 15% | 85% | 6,841 | 11 | Dominated |
| MNH-18: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 50% | 0.19 | 6% | 94% | 7,785 | 25 | Dominated |
| MNH-19: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 50% | 0.18 | 6% | 94% | 7,399 | 24 | Dominated |
| MNH-20: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 50% | 0.35 | 3% | 97% | 7,129 | 49 | Dominated |
| MNH-21: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 50% | 0.23 | 5% | 95% | 7,837 | 30 | Dominated |
| MNH-22: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 50% | 0.24 | 7% | 93% | 7,285 | 32 | Dominated |
| MNH-23: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 50% | 0.33 | 3% | 97% | 7,402 | 45 | Dominated |
| MNH-24: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 50% | 0.22 | 3% | 97% | 7,430 | 30 | Dominated |
| MNH-25: Management of vLBW + Management of serious newborn infections | 50% | 0.20 | 5% | 95% | 416 | 479 | Dominated |
| MNH-26: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 50% | 0.22 | 5% | 95% | 428 | 509 | Dominated |
| MNH-27: ENC | 50% | 0.24 | 5% | 95% | 493 | 482 | Dominated |
| MNH-28: ENC + Management of maternal sepsis | 50% | 0.35 | 4% | 96% | 497 | 712 | Dominated |
| MNH-29: Community newborn care package + Community-based pneumonia | 50% | 0.10 | 24% | 76% | 9,840 | 10 | Dominated |
| MNH-30: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 50% | 0.21 | 9% | 91% | 7,508 | 28 | Dominated |
| MNH-31: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 50% | 0.25 | 8% | 92% | 7,628 | 32 | Dominated |
| MNH-32: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 50% | 0.28 | 7% | 93% | 7,544 | 38 | Dominated |
| MNH-33: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 50% | 0.31 | 7% | 93% | 7,768 | 40 | Dominated |
| MNH-34: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 50% | 0.33 | 6% | 94% | 7,581 | 44 | Dominated |
| MNH-35: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 50% | 0.36 | 6% | 94% | 7,792 | 47 | Dominated |
| MNH-36: Community newborn care package + Tetanus Toxoid | 50% | 0.13 | 10% | 90% | 16,149 | 8 | Dominated |
| MNH-37: Community-based pneumonia + Tetanus Toxoid | 50% | 0.05 | 12% | 88% | 6,814 | 7 | 7 |
| MNH-38: Community-based pneumonia + ANC | 50% | 0.07 | 16% | 84% | 7,091 | 11 | Dominated |
| MNH-39: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 50% | 0.15 | 20% | 80% | 16,405 | 9 | Dominated |
| MNH-40: Support for breastfeeding mothers + Tetanus toxoid | 50% | 0.13 | 9% | 91% | 15,979 | 8 | Dominated |
| MNH-41: Community newborn care package + ANC | 50% | 0.16 | 12% | 88% | 16,426 | 10 | Dominated |
| MNH-42: Community newborn care package + ANC + Community-based pneumonia | 50% | 0.17 | 21% | 79% | 16,682 | 10 | Dominated |
| MNH-43: Community newborn care package + ANC + Community-based pneumonia + SMNC | 50% | 0.33 | 16% | 84% | 18,043 | 19 | Dominated |
| MNH-44: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 50% | 0.21 | 20% | 80% | 16,785 | 13 | Dominated |
| MNH-45: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 50% | 0.54 | 11% | 89% | 18,292 | 30 | Dominated |
| MNH-46: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 50% | 0.37 | 16% | 84% | 18,147 | 21 | Dominated |
| MNH-47: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 50% | 0.37 | 14% | 86% | 18,163 | 20 | Dominated |
| MNH-48: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 50% | 0.53 | 11% | 89% | 18,321 | 29 | Dominated |
| MNH-49: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.55 | 10% | 90% | 18,048 | 30 | Dominated |
| MNH-50: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 50% | 0.66 | 9% | 91% | 18,136 | 36 | Dominated |
| MNH-51: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 50% | 0.41 | 14% | 86% | 18,267 | 23 | Dominated |
| MNH-52: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 50% | 0.17 | 20% | 80% | 16,636 | 10 | Dominated |
| MNH-53: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 50% | 0.61 | 11% | 89% | 18,656 | 33 | Dominated |
| MNH-54: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 50% | 0.55 | 10% | 90% | 18,048 | 30 | Dominated |
| MNH-55: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 50% | 0.15 | 11% | 89% | 16,380 | 9 | Dominated |
| MNH-56: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.71 | 8% | 92% | 18,758 | 38 | Dominated |
| MNH-57: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 50% | 0.65 | 9% | 91% | 18,206 | 36 | Dominated |
| MNH-58: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 50% | 0.53 | 10% | 90% | 18,099 | 29 | Dominated |
| MNH-59: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 50% | 0.57 | 9% | 91% | 18,084 | 31 | Dominated |
| MNH-60: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 50% | 0.55 | 11% | 89% | 18,088 | 31 | Dominated |
| MNH-61: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 50% | 0.73 | 9% | 91% | 18,540 | 39 | Dominated |
| MNH-62: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 50% | 0.89 | 8% | 92% | 18,698 | 48 | Dominated |
| MNH-63: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.28 | 7% | 93% | 17,370 | 16 | Dominated |
| MNH-64: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.71 | 8% | 92% | 18,713 | 38 | Dominated |
| MNH-65: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 50% | 0.89 | 8% | 92% | 18,698 | 48 | Dominated |
| MNH-66: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 50% | 0.80 | 8% | 92% | 18,577 | 43 | Dominated |
| MNH-67: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 50% | 0.77 | 8% | 92% | 18,592 | 41 | Dominated |
| MNH-68: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 50% | 0.96 | 7% | 93% | 18,735 | 51 | Dominated |
| MNH-69: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 50% | 0.93 | 7% | 93% | 18,750 | 49 | Dominated |
| MNH-70: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 50% | 0.95 | 8% | 92% | 18,739 | 51 | Dominated |
| MNH-71: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 50% | 1.01 | 7% | 93% | 18,772 | 54 | Dominated |
| MNH-72: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 50% | 1.00 | 7% | 93% | 18,786 | 53 | Dominated |
| MNH-73: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 50% | 1.05 | 7% | 93% | 18,823 | 56 | Dominated |
| MNH-74: Community newborn care package + Tetanus Toxoid + SMNC | 50% | 0.28 | 8% | 92% | 17,524 | 16 | Dominated |
| MNH-75: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.30 | 12% | 88% | 17,625 | 17 | Dominated |
| MNH-76: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 50% | 0.30 | 13% | 87% | 17,780 | 17 | Dominated |
| MNH-77: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 50% | 0.30 | 8% | 92% | 17,601 | 17 | Dominated |
| MNH-78: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 50% | 0.32 | 13% | 87% | 17,857 | 18 | Dominated |
| MNH-79: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 50% | 0.43 | 6% | 94% | 17,485 | 24 | Dominated |
| MNH-80: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.44 | 9% | 91% | 17,741 | 25 | Dominated |
| MNH-81: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 50% | 0.43 | 6% | 94% | 17,640 | 24 | Dominated |
| MNH-82: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 50% | 0.44 | 9% | 91% | 17,741 | 25 | Dominated |
| MNH-83: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 50% | 0.45 | 10% | 90% | 17,896 | 25 | Dominated |
| MNH-84: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 50% | 0.36 | 12% | 88% | 18,132 | 20 | Dominated |
| MNH-85: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 50% | 0.54 | 9% | 91% | 18,016 | 30 | Dominated |
| MNH-86: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 50% | 0.43 | 10% | 90% | 18,168 | 24 | Dominated |
| MNH-87: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 50% | 0.40 | 11% | 89% | 18,183 | 22 | Dominated |
| MNH-88: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 50% | 0.47 | 9% | 91% | 18,220 | 26 | Dominated |
| MNH-89: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.83 | 7% | 93% | 18,597 | 45 | Dominated |
| MNH-90: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 50% | 0.84 | 7% | 93% | 18,643 | 45 | Dominated |
| MNH-91: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 50% | 0.89 | 7% | 93% | 18,680 | 48 | Dominated |
| MNH-92: Community newborn care package | 80% | 0.14 | 13% | 87% | 15,336 | 9 | Dominated |
| MNH-93: Support for breastfeeding mothers | 80% | 0.15 | 12% | 88% | 15,064 | 10 | Dominated |
| MNH-94: Pre-eclampsia screening | 80% | 0.06 | 14% | 86% | 258 | 235 | Dominated |
| MNH-95: Tetanus toxoid | 80% | 0.07 | 12% | 88% | 10,503 | 7 | Dominated |
| MNH-96: Screening & treatment of asymptomatic bacteriuria | 80% | 0.04 | 21% | 79% | 110 | 364 | Dominated |
| MNH-97: Screening & treatment of syphilis | 80% | 0.05 | 18% | 82% | 75 | 622 | Dominated |
| MNH-98: Normal delivery by a skilled attendant | 80% | 0.22 | 5% | 95% | 6,681 | 32 | Dominated |
| MNH-99: Community-based case management for neonatal pneumonia | 80% | 0.00 | 38% | 62% | 400 | 6 | Dominated |
| MNH-100: Normal delivery by a skilled attendant + Tetanus Toxoid | 80% | 0.28 | 4% | 96% | 11,591 | 24 | Dominated |
| MNH-101: Management of maternal sepsis | 80% | 0.17 | 2% | 98% | 103 | 1,653 | Dominated |
| MNH-102: Management of severe neonatal asphyxia | 80% | 0.04 | 26% | 74% | 19 | 2,231 | Dominated |
| MNH-103: Management of serious newborn infections | 80% | 0.18 | 6% | 94% | 500 | 359 | Dominated |
| MNH-104: Management of very low birth weight babies | 80% | 0.07 | 16% | 84% | 166 | 419 | Dominated |
| MNH-105: Manangement of neonatal jaundice | 80% | 0.04 | 27% | 73% | 7 | 6,014 | Dominated |
| MNH-106: Tetanus toxoid + Pre-eclampsia screening | 80% | 0.11 | 9% | 91% | 10,762 | 10 | Dominated |
| MNH-107: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 80% | 0.11 | 14% | 86% | 10,873 | 10 | Dominated |
| MNH-108: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 80% | 0.12 | 16% | 84% | 10,946 | 11 | Dominated |
| MNH-109: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 80% | 0.31 | 6% | 94% | 12,456 | 25 | Dominated |
| MNH-110: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 80% | 0.29 | 6% | 94% | 11,839 | 24 | Dominated |
| MNH-111: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 80% | 0.60 | 3% | 97% | 11,406 | 53 | Dominated |
| MNH-112: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 80% | 0.35 | 6% | 94% | 12,538 | 28 | Dominated |
| MNH-113: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 80% | 0.38 | 4% | 96% | 11,656 | 32 | Dominated |
| MNH-114: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 80% | 0.56 | 3% | 97% | 11,844 | 48 | Dominated |
| MNH-115: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 80% | 0.37 | 3% | 97% | 11,888 | 31 | Dominated |
| MNH-116: Management of vLBW + Management of serious newborn infections | 80% | 0.34 | 5% | 95% | 665 | 518 | Dominated |
| MNH-117: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 80% | 0.38 | 5% | 95% | 685 | 550 | Dominated |
| MNH-118: Emergency neonatal care | 80% | 0.41 | 5% | 95% | 788 | 520 | Dominated |
| MNH-119: ENC + Management of maternal sepsis | 80% | 0.61 | 4% | 96% | 795 | 765 | Dominated |
| MNH-120: Community newborn care package + Community-based pneumonia | 80% | 0.15 | 17% | 83% | 15,745 | 9 | Dominated |
| MNH-121: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 80% | 0.34 | 9% | 91% | 12,012 | 28 | Dominated |
| MNH-122: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 80% | 0.39 | 8% | 92% | 12,204 | 32 | Dominated |
| MNH-123: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 80% | 0.44 | 7% | 93% | 12,071 | 37 | Dominated |
| MNH-124: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 80% | 0.51 | 7% | 93% | 12,429 | 41 | Dominated |
| MNH-125: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 80% | 0.52 | 6% | 94% | 12,130 | 43 | Dominated |
| MNH-126: Tetanus toxoid + bacteruria + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 80% | 0.60 | 6% | 94% | 12,467 | 48 | Dominated |
| MNH-127: Community newborn care package + Tetanus Toxoid | 80% | 0.21 | 12% | 88% | 25,838 | 8 | Dominated |
| MNH-128: Community-based pneumonia + Tetanus Toxoid | 80% | 0.07 | 12% | 88% | 10,902 | 7 | 7 |
| MNH-129: Community-based pneumonia + ANC | 80% | 0.12 | 16% | 84% | 11,346 | 11 | Dominated |
| MNH-130: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 80% | 0.22 | 15% | 85% | 26,247 | 8 | Dominated |
| MNH-131: Support for breastfeeding mothers + Tetanus toxoid | 80% | 0.22 | 12% | 88% | 25,567 | 9 | Dominated |
| MNH-132: Community newborn care package + ANC | 80% | 0.26 | 14% | 86% | 26,282 | 10 | Dominated |
| MNH-133: Community newborn care package + ANC + Community-based pneumonia | 80% | 0.27 | 17% | 83% | 26,691 | 10 | Dominated |
| MNH-134: Community newborn care package + ANC + Community-based pneumonia + SMNC | 80% | 0.52 | 14% | 86% | 28,869 | 18 | Dominated |
| MNH-135: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 80% | 0.34 | 17% | 83% | 26,856 | 13 | Dominated |
| MNH-136: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 80% | 0.82 | 9% | 91% | 29,267 | 28 | Dominated |
| MNH-137: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 80% | 0.59 | 14% | 86% | 29,035 | 20 | Dominated |
| MNH-138: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 80% | 0.57 | 13% | 87% | 29,061 | 20 | Dominated |
| MNH-139: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 80% | 0.85 | 9% | 91% | 29,314 | 29 | Dominated |
| MNH-140: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.89 | 9% | 91% | 28,876 | 31 | Dominated |
| MNH-141: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 80% | 1.04 | 7% | 93% | 29,017 | 36 | Dominated |
| MNH-142: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 80% | 0.64 | 13% | 87% | 29,227 | 22 | Dominated |
| MNH-143: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 80% | 0.26 | 16% | 84% | 26,618 | 10 | Dominated |
| MNH-144: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 80% | 0.98 | 9% | 91% | 29,850 | 33 | Dominated |
| MNH-145: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 80% | 0.89 | 9% | 91% | 28,876 | 31 | Dominated |
| MNH-146: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 80% | 0.25 | 13% | 87% | 26,209 | 10 | Dominated |
| MNH-147: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.12 | 7% | 93% | 30,013 | 37 | Dominated |
| MNH-148: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 80% | 1.06 | 7% | 93% | 29,129 | 36 | Dominated |
| MNH-149: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 80% | 0.83 | 9% | 91% | 28,959 | 29 | Dominated |
| MNH-150: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 80% | 0.88 | 8% | 92% | 28,935 | 31 | Dominated |
| MNH-151: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 80% | 0.87 | 9% | 91% | 28,941 | 30 | Dominated |
| MNH-152: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 80% | 1.19 | 8% | 92% | 29,665 | 40 | Dominated |
| MNH-153: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 80% | 1.47 | 7% | 93% | 29,917 | 49 | Dominated |
| MNH-154: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.45 | 8% | 92% | 27,791 | 16 | Dominated |
| MNH-155: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.12 | 7% | 93% | 29,940 | 37 | Dominated |
| MNH-156: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 80% | 1.47 | 7% | 93% | 29,917 | 49 | Dominated |
| MNH-157: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 80% | 1.29 | 7% | 93% | 29,723 | 44 | Dominated |
| MNH-158: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 80% | 1.24 | 7% | 93% | 29,747 | 42 | Dominated |
| MNH-159: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 80% | 1.58 | 6% | 94% | 29,976 | 53 | Dominated |
| MNH-160: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 80% | 1.52 | 6% | 94% | 30,000 | 51 | Dominated |
| MNH-161: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.56 | 6% | 94% | 29,982 | 52 | Dominated |
| MNH-162: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 80% | 1.65 | 6% | 94% | 30,035 | 55 | Dominated |
| MNH-163: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 80% | 1.62 | 6% | 94% | 30,058 | 54 | Dominated |
| MNH-164: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 80% | 1.70 | 6% | 94% | 30,117 | 56 | Dominated |
| MNH-165: Community newborn care package + Tetanus Toxoid + SMNC | 80% | 0.45 | 10% | 90% | 28,039 | 16 | Dominated |
| MNH-166: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.46 | 10% | 90% | 28,201 | 16 | Dominated |
| MNH-167: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 80% | 0.46 | 11% | 89% | 28,448 | 16 | Dominated |
| MNH-168: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 80% | 0.48 | 9% | 91% | 28,162 | 17 | Dominated |
| MNH-169: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 80% | 0.49 | 10% | 90% | 28,571 | 17 | Dominated |
| MNH-170: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 80% | 0.69 | 6% | 94% | 27,977 | 25 | Dominated |
| MNH-171: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.70 | 7% | 93% | 28,386 | 25 | Dominated |
| MNH-172: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 80% | 0.70 | 7% | 93% | 28,224 | 25 | Dominated |
| MNH-173: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 80% | 0.70 | 7% | 93% | 28,386 | 25 | Dominated |
| MNH-174: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 80% | 0.71 | 8% | 92% | 28,634 | 25 | Dominated |
| MNH-175: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 80% | 0.55 | 11% | 89% | 29,011 | 19 | Dominated |
| MNH-176: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 80% | 0.87 | 7% | 93% | 28,826 | 30 | Dominated |
| MNH-177: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 80% | 0.66 | 9% | 91% | 29,069 | 23 | Dominated |
| MNH-178: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 80% | 0.60 | 10% | 90% | 29,094 | 21 | Dominated |
| MNH-179: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 80% | 0.71 | 8% | 92% | 29,152 | 24 | Dominated |
| MNH-180: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.32 | 6% | 94% | 29,755 | 45 | Dominated |
| MNH-181: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 80% | 1.33 | 6% | 94% | 29,828 | 45 | Dominated |
| MNH-182: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 80% | 1.41 | 6% | 94% | 29,887 | 47 | Dominated |
| MNH-183: Community newborn care package | 95% | 0.17 | 15% | 85% | 18,211 | 9 | Dominated |
| MNH-184: Support for breastfeeding mothers | 95% | 0.18 | 14% | 86% | 17,889 | 10 | Dominated |
| MNH-185: Pre-eclampsia screening | 95% | 0.08 | 15% | 85% | 306 | 262 | Dominated |
| MNH-186: Tetanus toxoid | 95% | 0.09 | 13% | 87% | 12,472 | 7 | Dominated |
| MNH-187: Screening & treatment of asymptomatic bacteriuria | 95% | 0.05 | 23% | 77% | 131 | 401 | Dominated |
| MNH-188: Screening & treatment of syphilis | 95% | 0.06 | 20% | 80% | 89 | 677 | Dominated |
| MNH-190: Normal delivery by a skilled attendant | 95% | 0.26 | 6% | 94% | 7,934 | 33 | Dominated |
| MNH-191: Community-based case management for neonatal pneumonia | 95% | 0.00 | 36% | 64% | 475 | 6 | 6 |
| MNH-193: Normal delivery by a skilled attendant + Tetanus Toxoid | 95% | 0.34 | 5% | 95% | 13,765 | 25 | Dominated |
| MNH-194: Management of maternal sepsis | 95% | 0.24 | 2% | 98% | 123 | 1,953 | Dominated |
| MNH-195: Management of severe neonatal asphyxia | 95% | 0.06 | 26% | 74% | 23 | 2,680 | Dominated |
| MNH-196: Management of serious newborn infections | 95% | 0.25 | 6% | 94% | 593 | 427 | Dominated |
| MNH-197: Management of very low birth weight babies | 95% | 0.10 | 16% | 84% | 197 | 502 | Dominated |
| MNH-198: Manangement of neonatal jaundice | 95% | 0.06 | 28% | 72% | 8 | 7,298 | Dominated |
| MNH-199: Tetanus toxoid + Pre-eclampsia screening | 95% | 0.14 | 10% | 90% | 12,780 | 11 | Dominated |
| MNH-200: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening | 95% | 0.14 | 14% | 86% | 12,912 | 11 | Dominated |
| MNH-201: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening | 95% | 0.15 | 17% | 83% | 12,998 | 12 | Dominated |
| MNH-202: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment | 95% | 0.37 | 7% | 93% | 14,791 | 25 | Dominated |
| MNH-203: Tetanus toxoid + Normal delivery by a skilled attendant + Resuscitation | 95% | 0.35 | 7% | 93% | 14,059 | 25 | Dominated |
| MNH-204: Tetanus toxoid + Normal delivery by a skilled attendant + Management of OL | 95% | 0.83 | 3% | 97% | 13,545 | 62 | Dominated |
| MNH-205: Tetanus toxoid + Normal delivery by a skilled attendant + Active management + Initial PPH treatment + Referral PPH treatment | 95% | 0.42 | 6% | 94% | 14,889 | 28 | Dominated |
| MNH-206: Tetanus toxoid + Normal delivery by a skilled attendant + Antibiotics pPROM | 95% | 0.49 | 5% | 95% | 13,842 | 35 | Dominated |
| MNH-207: Tetanus toxoid + Normal delivery by a skilled attendant + Steroids for pre-term | 95% | 0.77 | 3% | 97% | 14,065 | 55 | Dominated |
| MNH-208: Tetanus toxoid + Normal delivery by a skilled attendant + Treatment of severe PEE | 95% | 0.47 | 4% | 96% | 14,117 | 34 | Dominated |
| MNH-209: Management of vLBW + Management of serious newborn infections | 95% | 0.48 | 5% | 95% | 790 | 613 | Dominated |
| MNH-210: Management of vLBW + Management of serious newborn infections + Severe asphyxia | 95% | 0.53 | 4% | 96% | 813 | 651 | Dominated |
| MNH-211: Emergency neonatal care | 95% | 0.58 | 5% | 95% | 936 | 616 | Dominated |
| MNH-212: ENC + Management of maternal sepsis | 95% | 0.85 | 4% | 96% | 944 | 900 | Dominated |
| MNH-213: Community newborn care package + Community-based pneumonia | 95% | 0.17 | 15% | 85% | 18,697 | 9 | Dominated |
| MNH-214: Tetanus toxoid + Asymptomatic bacteriuria screening screening + Pre-eclampsia screening + Syphilis screening + Normal delivery by a skilled attendant | 95% | 0.41 | 10% | 90% | 14,264 | 29 | Dominated |
| MNH-215: Tetanus toxoid+Asymptomatic bacteriuria screening+Pre-eclampsia screening+Syphilis screening+Normal delivery by a skilled attendant+Treatment of severe PEE | 95% | 0.48 | 8% | 92% | 14,493 | 33 | Dominated |
| MNH-216: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Maternal sepsis referral | 95% | 0.54 | 7% | 93% | 14,334 | 38 | Dominated |
| MNH-217: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + Neonatal sepsis referral | 95% | 0.65 | 7% | 93% | 14,760 | 44 | Dominated |
| MNH-218: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Maternal sepsis referral | 95% | 0.65 | 6% | 94% | 14,404 | 45 | Dominated |
| MNH-219: Tetanus toxoid + Asymptomatic bacteriuria screening + Pre-eclampsia screening+ Syphilis screening + Normal delivery by a skilled attendant + antibiotics for pPROM + Neonatal sepsis referral | 95% | 0.79 | 6% | 94% | 14,804 | 53 | Dominated |
| MNH-221: Community newborn care package + Tetanus Toxoid | 95% | 0.26 | 15% | 85% | 30,683 | 9 | Dominated |
| MNH-222: Community-based pneumonia + Tetanus Toxoid | 95% | 0.10 | 14% | 86% | 12,947 | 7 | Dominated |
| MNH-223: Community-based pneumonia + ANC | 95% | 0.15 | 17% | 83% | 13,473 | 11 | Dominated |
| MNH-224: Community newborn care package + Tetanus Toxoid + Community-based pneumonia | 95% | 0.27 | 14% | 86% | 31,169 | 9 | 9 |
| MNH-225: Support for breastfeeding mothers + Tetanus toxoid | 95% | 0.27 | 14% | 86% | 30,361 | 9 | Dominated |
| MNH-227: Community newborn care package + ANC | 95% | 0.32 | 16% | 84% | 31,209 | 10 | Dominated |
| MNH-228: Community newborn care package + ANC + Community-based pneumonia | 95% | 0.32 | 16% | 84% | 31,695 | 10 | 108 |
| MNH-229: Community newborn care package + ANC + Community-based pneumonia + SMNC | 95% | 0.62 | 14% | 86% | 34,282 | 18 | 114 |
| MNH-230: Community newborn care package + ANC + Community-based pneumonia + Management of vLBW | 95% | 0.42 | 16% | 84% | 31,892 | 13 | Dominated |
| MNH-232: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Antibiotics pPROM | 95% | 1.02 | 9% | 91% | 34,755 | 29 | Dominated |
| MNH-233: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.72 | 14% | 86% | 34,479 | 21 | Dominated |
| MNH-235: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE | 95% | 0.69 | 12% | 88% | 34,510 | 20 | 304 |
| MNH-236: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Steroids pre-term | 95% | 1.11 | 8% | 92% | 34,810 | 32 | Dominated |
| MNH-237: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.18 | 8% | 92% | 34,291 | 34 | Dominated |
| MNH-240: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Referral PPH + Maternal sepsis + Management of OL | 95% | 1.36 | 7% | 93% | 34,458 | 40 | Dominated |
| MNH-241: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of vLBW | 95% | 0.79 | 13% | 87% | 34,707 | 23 | 502 |
| MNH-242: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Community-based pneumonia | 95% | 0.31 | 15% | 85% | 31,609 | 10 | Dominated |
| MNH-243: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + ENC | 95% | 1.26 | 9% | 91% | 35,446 | 36 | Dominated |
| MNH-244: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL | 95% | 1.18 | 8% | 92% | 34,291 | 34 | Dominated |
| MNH-245: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening | 95% | 0.31 | 15% | 85% | 31,123 | 10 | Dominated |
| MNH-246: Community newborn care package + ANC + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.44 | 7% | 93% | 35,641 | 40 | 905 |
| MNH-247: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term | 95% | 1.40 | 7% | 93% | 34,591 | 40 | Dominated |
| MNH-248: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Referral PPH | 95% | 1.03 | 8% | 92% | 34,389 | 30 | Dominated |
| MNH-249: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Management of maternal sepsis | 95% | 1.10 | 8% | 92% | 34,360 | 32 | Dominated |
| MNH-250: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + Antibiotics pPROM | 95% | 1.12 | 8% | 92% | 34,368 | 32 | Dominated |
| MNH-251: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC | 95% | 1.55 | 7% | 93% | 35,227 | 44 | Dominated |
| MNH-252: Community newborn care package + ANC + Community-based pneumonia + SMNC + Treatment of severe PEE + Management of OL + ENC + Steroids pre-term | 95% | 1.97 | 6% | 94% | 35,527 | 56 | Dominated |
| MNH-253: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.54 | 10% | 90% | 33,002 | 16 | Dominated |
| MNH-254: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.43 | 7% | 93% | 35,554 | 40 | Dominated |
| MNH-255: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Community-based pneumonia care | 95% | 1.97 | 6% | 94% | 35,527 | 56 | Dominated |
| MNH-256: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Maternal sepsis + Community-based pneumonia care | 95% | 1.68 | 7% | 93% | 35,296 | 48 | Dominated |
| MNH-257: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia care | 95% | 1.60 | 7% | 93% | 35,325 | 45 | Dominated |
| MNH-258: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Community-based pneumonia care | 95% | 2.11 | 6% | 94% | 35,596 | 59 | Dominated |
| MNH-259: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + PPH referral + Community-based pneumonia care | 95% | 2.03 | 6% | 94% | 35,625 | 57 | Dominated |
| MNH-260: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.12 | 6% | 94% | 35,604 | 59 | Dominated |
| MNH-261: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + Community-based pneumonia care | 95% | 2.21 | 5% | 95% | 35,666 | 62 | Dominated |
| MNH-262: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + PPH referral + Community-based pneumonia care | 95% | 2.16 | 6% | 94% | 35,694 | 61 | Dominated |
| MNH-263: Community newborn care package + ANC + ENC + SMNC + Treatment of severe PEE + Management of OL + Steroids pre-term + Maternal sepsis + Antibiotics pPROM + PPH referral + Community-based pneumonia care | 95% | 2.26 | 5% | 95% | 35,764 | 63 | 31,766 |
| MNH-264: Community newborn care package + Tetanus Toxoid + SMNC | 95% | 0.55 | 11% | 89% | 33,296 | 16 | Dominated |
| MNH-265: Community newborn care package + Tetanus Toxoid + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.54 | 10% | 90% | 33,488 | 16 | Dominated |
| MNH-266: Community newborn care package + Tetanus Toxoid + SMNC + Community-based pneumonia | 95% | 0.55 | 11% | 89% | 33,782 | 16 | Dominated |
| MNH-267: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH | 95% | 0.59 | 10% | 90% | 33,442 | 18 | Dominated |
| MNH-268: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Community-based pneumonia | 95% | 0.59 | 10% | 90% | 33,928 | 17 | Dominated |
| MNH-269: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL | 95% | 0.87 | 7% | 93% | 33,222 | 26 | Dominated |
| MNH-270: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.87 | 7% | 93% | 33,708 | 26 | Dominated |
| MNH-271: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL | 95% | 0.88 | 8% | 92% | 33,517 | 26 | Dominated |
| MNH-272: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + Normal delivery by a skilled attendant + Active management and initial treatment of PPH + Management of OL + Community-based pneumonia | 95% | 0.87 | 7% | 93% | 33,708 | 26 | Dominated |
| MNH-273: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Management of OL + Community-based pneumonia | 95% | 0.88 | 8% | 92% | 34,002 | 26 | Dominated |
| MNH-274: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia | 95% | 0.67 | 10% | 90% | 34,450 | 19 | Dominated |
| MNH-275: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Management of OL | 95% | 1.16 | 7% | 93% | 34,231 | 34 | Dominated |
| MNH-276: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Community-based pneumonia + Maternal sepsis | 95% | 0.80 | 9% | 91% | 34,520 | 23 | Dominated |
| MNH-277: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia | 95% | 0.72 | 10% | 90% | 34,549 | 21 | Dominated |
| MNH-278: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + PPH referral + Community-based pneumonia + Maternal sepsis | 95% | 0.85 | 8% | 92% | 34,618 | 25 | Dominated |
| MNH-279: Community newborn care package + Tetanus Toxoid + Pre-eclampsia screening + Asymptomatic bacteriuria screening + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.72 | 6% | 94% | 35,334 | 49 | Dominated |
| MNH-280: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC | 95% | 1.73 | 6% | 94% | 35,421 | 49 | Dominated |
| MNH-281: Community newborn care package + ANC + SMNC + Treatment of severe PEE + Management of OL + PPH referral + Community-based pneumonia + Maternal sepsis + ENC + Antibiotics pPROM | 95% | 1.83 | 6% | 94% | 35,491 | 52 | Dominated |
| MNH-282: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.14 | 10% | 90% | 34,778 | 33 | Dominated |
| MNH-283: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW | 95% | 0.65 | 12% | 88% | 33,979 | 19 | Dominated |
| MNH-284: Community newborn care package + Tetanus toxoid + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term | 95% | 1.07 | 8% | 92% | 34,279 | 31 | Dominated |
| MNH-285: Community newborn care package + ANC + Community-based pneumonia + SMNC + Management of vLBW + Steroids pre-term + Treatment of severe PEE | 95% | 1.21 | 9% | 91% | 35,007 | 35 | Dominated |
| MNH-286: Community newborn care package + ANC + Community-based pneumonia + SMNC + ENC + Steroids pre-term + Treatment of severe PEE | 95% | 1.69 | 7% | 93% | 35,746 | 47 | 2,353 |